Shares of ZIOPHARM Oncology (NASDAQ: ZIOP) were 16.8% higher as of 3:11 p.m. EDT on Tuesday. The big move in the biotech's share price is likely related to ZIOPHARM's announcement earlier in the day of changes to its board of directors.The company issued a press release announcing that two of its current board members, Sir Murray Brennan and Sen.